Related Experiment Videos
Studies on cytosolic guanylate cyclase from human placenta
S D Idriss1, R B Pilz, V S Sharma
1Department of Medicine, University of California, San Diego, La Jolla 92093-0652.
Biochemical and Biophysical Research Communications
|February 28, 1992
Summary
Researchers purified soluble guanylate cyclase from human placenta. This enzyme showed unique properties, including lower nitric oxide activation, suggesting differences in its heme prosthetic group structure compared to other sources.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Soluble guanylate cyclase (sGC) is a key enzyme in cellular signaling pathways.
- Understanding the structural and functional properties of sGC from different sources is crucial for elucidating its biological roles.
Purpose of the Study:
- To purify and characterize the soluble form of guanylate cyclase from human placenta.
- To compare its properties with sGC from other mammalian tissues.
Main Methods:
- Purification of soluble guanylate cyclase from human placenta using established biochemical techniques.
- Characterization of enzyme kinetics, activation, and spectral properties.
Main Results:
- Human placental sGC was purified over 2400-fold.
- The enzyme exhibited similar molecular mass and subunit composition to sGC from other sources.
- Unique spectral properties and significantly lower nitric oxide activation were observed compared to bovine lung sGC.
Conclusions:
- The human placental sGC enzyme possesses distinct characteristics, particularly in its response to nitric oxide.
- These differences may stem from variations in the coordination state of the heme prosthetic group, potentially hexa-coordinate in human placenta and penta-coordinate in bovine lung.